Nicholas Opoku

2.1k total citations
34 papers, 866 citations indexed

About

Nicholas Opoku is a scholar working on Infectious Diseases, Health, Toxicology and Mutagenesis and Parasitology. According to data from OpenAlex, Nicholas Opoku has authored 34 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 14 papers in Health, Toxicology and Mutagenesis and 14 papers in Parasitology. Recurrent topics in Nicholas Opoku's work include Parasitic Diseases Research and Treatment (28 papers), Insects and Parasite Interactions (14 papers) and Parasites and Host Interactions (14 papers). Nicholas Opoku is often cited by papers focused on Parasitic Diseases Research and Treatment (28 papers), Insects and Parasite Interactions (14 papers) and Parasites and Host Interactions (14 papers). Nicholas Opoku collaborates with scholars based in Ghana, Switzerland and United Kingdom. Nicholas Opoku's co-authors include Simon K. Attah, E. T. Addy, K. Awadzi, Benjamin Quartey, Janis K. Lazdins-Helds, Kwablah Awadzi, Annette C. Kuesel, Daniel A. Boakye, Boachie Boatin and Alison Ardrey and has published in prestigious journals such as PLoS ONE, American Journal of Tropical Medicine and Hygiene and PLoS neglected tropical diseases.

In The Last Decade

Nicholas Opoku

33 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas Opoku Ghana	15	657	417	407	196	176	34	866
Kwablah Awadzi Ghana	17	673 1.0×	442 1.1×	429 1.1×	183 0.9×	196 1.1×	20	1.0k
Michael T. Dzimianski United States	17	487 0.7×	287 0.7×	240 0.6×	78 0.4×	143 0.8×	42	698
Catherine Bourguinat Canada	19	650 1.0×	639 1.5×	606 1.5×	86 0.4×	438 2.5×	26	1.1k
Dominique Kyelem United States	12	488 0.7×	365 0.9×	282 0.7×	65 0.3×	83 0.5×	16	670
M Karam Burkina Faso	15	1.2k 1.8×	583 1.4×	637 1.6×	370 1.9×	87 0.5×	26	1.4k
K. Awadzi United Kingdom	24	1.3k 2.0×	711 1.7×	710 1.7×	525 2.7×	351 2.0×	57	1.7k
P Gaxotte France	13	474 0.7×	327 0.8×	192 0.5×	169 0.9×	107 0.6×	34	704
M. D. Soll United States	17	426 0.6×	287 0.7×	171 0.4×	43 0.2×	276 1.6×	55	810
Büttner Dw Germany	12	395 0.6×	197 0.5×	199 0.5×	141 0.7×	59 0.3×	29	531
Dorn Watthanakulpanich Thailand	16	93 0.1×	397 1.0×	235 0.6×	45 0.2×	141 0.8×	49	604

Countries citing papers authored by Nicholas Opoku

Since Specialization

Citations

This map shows the geographic impact of Nicholas Opoku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Opoku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Opoku more than expected).

Fields of papers citing papers by Nicholas Opoku

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Opoku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Opoku. The network helps show where Nicholas Opoku may publish in the future.

Co-authorship network of co-authors of Nicholas Opoku

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Opoku. A scholar is included among the top collaborators of Nicholas Opoku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Opoku. Nicholas Opoku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Opoku, Nicholas, et al.. (2024). Seismic activities in Ghana: A systematic review. Heliyon. 10(10). e31536–e31536.

Kanza, Eric M., Nicholas Opoku, Didier Bakajika, et al.. (2024). Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia. Parasites & Vectors. 17(1). 137–137. 1 indexed citations

Manu, Emmanuel, et al.. (2024). Lay beliefs of COVID-19 vaccine refusal among intercity commercial drivers in the Volta region of Ghana: recommendations for improved vaccine uptake. Tropical Diseases Travel Medicine and Vaccines. 10(1). 5–5. 1 indexed citations

Pfarr, Kenneth, Hannah Batchelor, Michel Vaillant, et al.. (2023). The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use. Parasites & Vectors. 16(1). 394–394. 10 indexed citations

Pfarr, Kenneth, Hannah Batchelor, Michel Vaillant, et al.. (2023). The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration. Parasites & Vectors. 16(1). 82–82. 18 indexed citations

Opoku, Nicholas, Bettina Dubben, Kerstin Fischer, et al.. (2023). A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis. PLoS neglected tropical diseases. 17(5). e0011365–e0011365. 4 indexed citations

Bakajika, Didier, Eric M. Kanza, Nicholas Opoku, et al.. (2022). Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection. PLoS neglected tropical diseases. 16(4). e0010079–e0010079. 9 indexed citations

Opoku, Nicholas, et al.. (2022). Evaluation of Non-Invasive Thermal Imaging for Detection of Viability of Onchocerciasis Worms. 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). 2022. 3518–3521. 1 indexed citations

Silk, Sarah E., Gordon A. Awandare, Simon J. Draper, et al.. (2018). Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria. PLoS ONE. 13(6). e0198371–e0198371. 26 indexed citations

10.

Jamsen, Kris M., Carl M. J. Kirkpatrick, Nicholas Opoku, et al.. (2017). DETERMINING THE OPTIMAL DOSE OF MOXIDECTIN FOR ONCHOCERCIASIS VIA PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELLING OF DATA FROM HEALTHY VOLUNTEERS AND PATIENTS WITH ONCHOCERCIASIS. American Journal of Tropical Medicine and Hygiene. 97(5). 238–239. 3 indexed citations

11.

Bottomley, Christian, Valerie Isham, Sarai Vivas-Martínez, et al.. (2016). Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings. Parasites & Vectors. 9(1). 343–343. 23 indexed citations

12.

Turner, Hugo C., Martin Walker, Simon K. Attah, et al.. (2015). The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasites & Vectors. 8(1). 167–167. 60 indexed citations

13.

Awadzi, Kwablah, Nicholas Opoku, Simon K. Attah, Janis K. Lazdins-Helds, & Annette C. Kuesel. (2014). A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection. PLoS neglected tropical diseases. 8(6). e2953–e2953. 86 indexed citations

14.

Opoku, Nicholas, Didier Bakajika, Eric M. Kanza, et al.. (2013). Efficacy of a single oral dose of 8 mg Moxidectin vs. 150 mu g/kg ivermectin in onchocerca volvulus infection: results of a randomized, double-blind single dose phase 3 study in areas without mass treatment with ivermectin in Liberia, Ghana and DRC. Tropical Medicine & International Health. 18. 58–58. 3 indexed citations

15.

Awadzi, K., Daniel A. Boakye, G. Edwards, et al.. (2004). An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Annals of Tropical Medicine and Parasitology. 98(3). 231–249. 169 indexed citations

16.

Awadzi, K., G. Edwards, Nicholas Opoku, et al.. (2004). The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Annals of Tropical Medicine and Parasitology. 98(6). 595–614. 30 indexed citations

17.

Awadzi, K., Simon K. Attah, E. T. Addy, et al.. (2004). Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Annals of Tropical Medicine and Parasitology. 98(4). 359–370. 111 indexed citations

18.

Awadzi, K., Geoffrey Edwards, B. O. L. Duke, et al.. (2003). The co-administration of ivermectin and albendazole - safety, pharmacokinetics and efficacy against Onchocerca volvulus. Annals of Tropical Medicine and Parasitology. 97(2). 165–178. 54 indexed citations

19.

Lavebratt, Catharina, et al.. (1994). A simple dot blot assay adaptable for field use in the diagnosis of onchocerciasis: preparation of an adult worm antigen fraction which enhances sensitivity and specificity. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(3). 303–306. 18 indexed citations

20.

Büttner, Dietrich W., K. Awadzi, & Nicholas Opoku. (1990). Histological studies of onchocercomata from an area with interrupted transmission in Ghana.. PubMed. 59(1-2). 49–50. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact